Welcome!

News Feed Item

Tic Disorder Global Clinical Trials Review, H2, 2014

NEW YORK, Aug. 11, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Tic Disorder Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02280950/Tic-Disorder-Global-Clinical-Trials-Review-H2-2014.html

Tic Disorder Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Tic Disorder Global Clinical Trials Review, H2, 2014" provides data on the Tic Disorder clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tic Disorder. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tic Disorder. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Tic Disorder 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Tic Disorder to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Tic Disorder to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Tic Disorder 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Tic Disorder Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Otsuka Holdings Co., Ltd. 30
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 30
Tasly Pharmaceuticals, Inc. 31
Clinical Trial Overview of Tasly Pharmaceuticals, Inc. 31
Clinical Trial Overview of Top Institutes / Government 32
National Institute of Neurological Disorders and Stroke 32
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 32
National Institute of Mental Health 33
Clinical Trial Overview of National Institute of Mental Health 33
Yale University 34
Clinical Trial Overview of Yale University 34
Parkinson's Disease and Movement Disorder Center of Boca Raton 35
Clinical Trial Overview of Parkinson's Disease and Movement Disorder Center of Boca Raton 35
Shiraz University of Medical Sciences 36
Clinical Trial Overview of Shiraz University of Medical Sciences 36
University of California, Los Angeles 37
Clinical Trial Overview of University of California, Los Angeles 37
New York University School of Medicine 38
Clinical Trial Overview of New York University School of Medicine 38
National Center for Research Resources 39
Clinical Trial Overview of National Center for Research Resources 39
Massachusetts General Hospital 40
Clinical Trial Overview of Massachusetts General Hospital 40
Washington University School of Medicine 41
Clinical Trial Overview of Washington University School of Medicine 41
Five Key Clinical Profiles 42
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 69

List of Tables

Tic Disorder Therapeutics, Global, Clinical Trials by Region, 2014* 7
Tic Disorder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Tic Disorder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Tic Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Tic Disorder Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Tic Disorder Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Tic Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Tic Disorder Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Tic Disorder to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Tic Disorder Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Tic Disorder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Tic Disorder to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Tic Disorder Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Tic Disorder Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Tic Disorder Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Tic Disorder Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Tic Disorder Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Tic Disorder Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Tic Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Tic Disorder Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Tic Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Tic Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Tic Disorder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 30
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Tasly Pharmaceuticals, Inc., 2014* 31
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 32
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 33
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 34
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Parkinson's Disease and Movement Disorder Center of Boca Raton, 2014* 35
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2014* 36
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014* 37
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014* 38
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 39
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 40
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 41

List of Figures

Tic Disorder Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Tic Disorder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Tic Disorder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Tic Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Tic Disorder Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Tic Disorder Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Tic Disorder Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Tic Disorder to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Tic Disorder Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Tic Disorder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Tic Disorder to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Tic Disorder Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Tic Disorder Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Tic Disorder Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Tic Disorder Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Tic Disorder Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Tic Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Tic Disorder Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Tic Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Tic Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Tic Disorder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 68


To order this report: Tic Disorder Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02280950/Tic-Disorder-Global-Clinical-Trials-Review-H2-2014.html



__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
As businesses adopt functionalities in cloud computing, it’s imperative that IT operations consistently ensure cloud systems work correctly – all of the time, and to their best capabilities. In his session at @BigDataExpo, Bernd Harzog, CEO and founder of OpsDataStore, presented an industry answer to the common question, “Are you running IT operations as efficiently and as cost effectively as you need to?” He then expounded on the industry issues he frequently came up against as an analyst, and ...
Cloud resources, although available in abundance, are inherently volatile. For transactional computing, like ERP and most enterprise software, this is a challenge as transactional integrity and data fidelity is paramount – making it a challenge to create cloud native applications while relying on RDBMS. In his session at 21st Cloud Expo, Claus Jepsen, Chief Architect and Head of Innovation Labs at Unit4, will explore that in order to create distributed and scalable solutions ensuring high availa...
SYS-CON Events announced today that App2Cloud will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct. 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. App2Cloud is an online Platform, specializing in migrating legacy applications to any Cloud Providers (AWS, Azure, Google Cloud).
Historically, some banking activities such as trading have been relying heavily on analytics and cutting edge algorithmic tools. The coming of age of powerful data analytics solutions combined with the development of intelligent algorithms have created new opportunities for financial institutions. In his session at 20th Cloud Expo, Sebastien Meunier, Head of Digital for North America at Chappuis Halder & Co., discussed how these tools can be leveraged to develop a lasting competitive advantage ...
In his session at @DevOpsSummit at 20th Cloud Expo, Kelly Looney, director of DevOps consulting for Skytap, showed how an incremental approach to introducing containers into complex, distributed applications results in modernization with less risk and more reward. He also shared the story of how Skytap used Docker to get out of the business of managing infrastructure, and into the business of delivering innovation and business value. Attendees learned how up-front planning allows for a clean sep...
IoT is at the core or many Digital Transformation initiatives with the goal of re-inventing a company's business model. We all agree that collecting relevant IoT data will result in massive amounts of data needing to be stored. However, with the rapid development of IoT devices and ongoing business model transformation, we are not able to predict the volume and growth of IoT data. And with the lack of IoT history, traditional methods of IT and infrastructure planning based on the past do not app...
Enterprise architects are increasingly adopting multi-cloud strategies as they seek to utilize existing data center assets, leverage the advantages of cloud computing and avoid cloud vendor lock-in. This requires a globally aware traffic management strategy that can monitor infrastructure health across data centers and end-user experience globally, while responding to control changes and system specification at the speed of today’s DevOps teams. In his session at 20th Cloud Expo, Josh Gray, Chie...
Internet-of-Things discussions can end up either going down the consumer gadget rabbit hole or focused on the sort of data logging that industrial manufacturers have been doing forever. However, in fact, companies today are already using IoT data both to optimize their operational technology and to improve the experience of customer interactions in novel ways. In his session at @ThingsExpo, Gordon Haff, Red Hat Technology Evangelist, shared examples from a wide range of industries – including en...
In IT, we sometimes coin terms for things before we know exactly what they are and how they’ll be used. The resulting terms may capture a common set of aspirations and goals – as “cloud” did broadly for on-demand, self-service, and flexible computing. But such a term can also lump together diverse and even competing practices, technologies, and priorities to the point where important distinctions are glossed over and lost.
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. Jack Norris reviews best practices to show how companies develop, deploy, and dynamically update these applications and how this data-first...
Intelligent Automation is now one of the key business imperatives for CIOs and CISOs impacting all areas of business today. In his session at 21st Cloud Expo, Brian Boeggeman, VP Alliances & Partnerships at Ayehu, will talk about how business value is created and delivered through intelligent automation to today’s enterprises. The open ecosystem platform approach toward Intelligent Automation that Ayehu delivers to the market is core to enabling the creation of the self-driving enterprise.
"At the keynote this morning we spoke about the value proposition of Nutanix, of having a DevOps culture and a mindset, and the business outcomes of achieving agility and scale, which everybody here is trying to accomplish," noted Mark Lavi, DevOps Solution Architect at Nutanix, in this SYS-CON.tv interview at @DevOpsSummit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We're here to tell the world about our cloud-scale infrastructure that we have at Juniper combined with the world-class security that we put into the cloud," explained Lisa Guess, VP of Systems Engineering at Juniper Networks, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We're a cybersecurity firm that specializes in engineering security solutions both at the software and hardware level. Security cannot be an after-the-fact afterthought, which is what it's become," stated Richard Blech, Chief Executive Officer at Secure Channels, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
In his session at 20th Cloud Expo, Mike Johnston, an infrastructure engineer at Supergiant.io, discussed how to use Kubernetes to set up a SaaS infrastructure for your business. Mike Johnston is an infrastructure engineer at Supergiant.io with over 12 years of experience designing, deploying, and maintaining server and workstation infrastructure at all scales. He has experience with brick and mortar data centers as well as cloud providers like Digital Ocean, Amazon Web Services, and Rackspace. H...